Evaluation of Plasma Fibrinogen Degradation Products and Total Serum Protein Concentration in Oral Submucous Fibrosis

Dayanandam, M.; Pushpanjali, .; Divya, S; Satyasree, M.; Pasupuleti, Pravallika; Sultana, Juweria

doi:10.5958/2347-6206.2017.00021.8

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dayanandam et al [ 15 ] carried a study to assess the plasma FDP levels in OSMF. Twenty-five clinically diagnosed OSMF patients with AN-chewing behaviors, and 25 healthy controls without any harmful habits were involved in the study.…”

Section: Discussionmentioning

confidence: 99%

Plasma fibrinogen degradation products as the nonsurgical diagnostic tool for oral submucous fibrosis: A systematic review

Gupta,

Sandhu,

Nadar

et al. 2023

J Int Soc Prevent Communit Dent

View full text Add to dashboard Cite

A BSTRACT Aims and Objectives: Oral submucous fibrosis (OSMF) is known to be one of the most common premalignant conditions of the oral cavity. Areca nut (AN) is considered to be the disease’s primary cause, while there are other potential causes as well. However, routine clinical practice has revealed that not all people who chew AN exhibit clinical signs of OSMF, and few people are reported to have it even without chewing AN. So, there must be other factors contributing to OSMF. Plasma fibrinogen degradation products (FDPs) have recently been discovered to be an early sign of this disease, indicating a potential link between the two. This review aims to examine the studies which have been published in the literature that explain the role of plasma FDPs in contributing to OSMF. Materials and Methods: An electronic search of the published literature was performed without publication year limitation in PubMed/ Medline, Scopus, Google Scholar, Web of Science, Science Direct, Embase, and Research gate databases, using mesh keywords like (‘Oral submucous fibrosis’ OR ‘Oral submucous fibrosis’) AND (‘Fibrinogen degradation products’ OR ‘Plasma fibrinogen degradation products’) AND (‘Clinical grades’ OR ‘Histological grades’) AND (‘Diagnosis’). A manual search of all related journals was also done. We also referred to the reference lists of papers. The risk of bias was evaluated with the GRADE criteria (from the Grading of Recommendations Assessment, Development, and Evaluation Working Group). Results: The search revealed a total of 12 relevant studies from 1979 to 2022. Nine out of 12 studies demonstrated the definite presence of plasma FDPs in such cases. Conclusions: Although the studies documented in the literature showing evidence of plasma FDPs in patients with OSMF are very few in number, their detection signifies an important clinical finding. More research is still required in this aspect to establish stronger evidence.

show abstract

Section: Discussionmentioning

confidence: 99%